This review demonstrates emerging strategies in olfactory restoration for diseases like Alzheimer’s and Parkinson’s, highlighting electrical stimulation and neural regeneration.
Olfactory dysfunction (OD) is an early symptom associated with a variety of diseases, including COVID-19, Alzheimer’s disease, and Parkinson’s disease, where patients commonly experience hyposmia or anosmia. Effective restoration of olfactory function is therefore crucial for disease diagnosis and management, and improving overall quality of life. Traditional treatment approaches have primarily relied on medication and surgical intervention. However, recent advances in bionic sensing and brain–computer interface (BCI) technologies have opened up novel avenues for olfactory rehabilitation, facilitating the reconstruction of neural circuits and the enhancement of connectivity within the central nervous system. This review provides an overview of the current research landscape on OD-related diseases and highlights emerging olfactory restoration strategies, including olfactory training (OT), electrical stimulation, neural regeneration, and BCI-based approaches. These developments lay a theoretical foundation for achieving more rapid and reliable clinical recovery of olfactory function.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: